CoChat

Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy

Horak, Friedrich, Petra Zieglmayer, Ursula, Zieglmayer, René, Kavina, Alexander, Marschall, Kristina, Munzel, Ullrich, Petzold, Ursula · 2006 · Current Medical Research and Opinion

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To assess the efficacy and onset of action of azelastine nasal spray and desloratadine tablets in patients with allergen-induced seasonal allergic rhinitis (SAR). RESEARCH DESIGN AND METHODS: 46 adult patients with a history of SAR were exposed to a controlled grass pollen concentration for 6 h in the Vienna Challenge Chamber (VCC) in each treatment period according to a randomised, double-blind (double-dummy), three-period, three-sequence crossover design (wash-out period of 12 days). Single doses of study medication (one puff nasal spray into each nostril of azelastine, 0.2 mg, or placebo before swallowing one encapsulated tablet of desloratadine, 5 mg) were administered 2 h after the start of the allergen challenge. Results of subjective and objective assessments were recorded throughout the challenge. RESULTS: Efficacy of azelastine nasal spray was significantly superior compared to desloratadine tablets (p = 0.005) and placebo (p < 0.001). Desloratadine was significantly better than placebo (p < 0.001). Decrease both in Major Nasal Symptom Score (MNSS) and in Total Nasal Symptom Score (TNSS) was fastest after azelastine treatment. Improvement of nasal symptom severity was most pronounced after azelastine treatment for all nasal symptoms including nasal congestion. Onset of action was 15 min for azelastine compared to 150 min for desloratadine. Both active preparations were safe and well tolerated. CONCLUSIONS: This study confirms the usefulness of azelastine nasal spray for the symptomatic treatment of seasonal allergic rhinitis. Concerning onset of action in particular, the results favour the topical treatment over systemic therapy.

Overview

Integrity signals

Registry

Crossref · 10.1185/030079906x80305

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 14 references

Research works printed but not linked: 4

  1. Horak F, 1987, Wien Klin Wochenschr, 99, 509
  2. Horak F, 2001, d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis. Int Arch Allergy Immunol, 125, 73
  3. Baumgarten CR, 1994, J Pharmacol Ther, 3, 43
  4. Horak F, 2000, Allergy, 55, S279

Cited by

See all 98

Metadata

Authors
Horak, F., Petra Zieglmayer, U., Zieglmayer, R., Kavina, A., Marschall, K., Munzel, U., & Petzold, U.
Affiliations
  • Allergiezentrum Wien West (AT)
  • Hochbahn (Germany) (DE)
Corresponding author
Horak, Friedrich
Venue
Current Medical Research and Opinion
Published
2005-12
Volume
22
Issue
1
Pages
151-157
ISSN
  • 0300-7995 (ISSN-L)
  • 1473-4877
OpenAlex
W2150163190
Cited by
98
References
14
Citations by year
2025: 3 · 2024: 4 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 13 · 2018: 6 · 2017: 6 · 2016: 6 · 2015: 3 · 2014: 3 · 2013: 5 · 2012: 1
FWCI
2.99
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medical Research and Opinion (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
Keywords
desloratadine, allergic rhinitis, onset of action, nasal congestion, nasal symptom score
MeSH terms
Administration, Intranasal, Adolescent, Adult, Female, Rhinitis, Allergic, Seasonal, Humans, Male, Middle Aged, Phthalazines, Pollen, Tablets, Treatment Outcome, Loratadine, Anti-Allergic Agents, Histamine H1 Antagonists, Non-Sedating

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. https://app.cochat.ai/papers/10.1185/030079906x80305
The paper
Horak, F., Petra Zieglmayer, U., Zieglmayer, R., Kavina, A., Marschall, K., Munzel, U., & Petzold, U. (2006). Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. Current Medical Research and Opinion. https://doi.org/10.1185/030079906x80305

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.